Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Boehringer Ingelheim
Argus Health
Julphar
Dow
Moodys
Cerilliant
Chubb

Generated: January 23, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020989

« Back to Dashboard

NDA 020989 describes EVOXAC, which is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the EVOXAC profile page.

The generic ingredient in EVOXAC is cevimeline hydrochloride. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cevimeline hydrochloride profile page.
Summary for 020989
Tradename:EVOXAC
Applicant:Daiichi Sankyo Inc
Ingredient:cevimeline hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020989
Suppliers and Packaging for NDA: 020989
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EVOXAC cevimeline hydrochloride CAPSULE;ORAL 020989 NDA Sun Pharmaceutical Industries, Inc. 63304-479 63304-479-01 100 CAPSULE in 1 BOTTLE (63304-479-01)
EVOXAC cevimeline hydrochloride CAPSULE;ORAL 020989 NDA Daiichi Sankyo, Inc. 63395-201 63395-201-13 100 CAPSULE in 1 BOTTLE, PLASTIC (63395-201-13)

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength30MG
Approval Date:Jan 11, 2000TE:ABRLD:Yes

Expired US Patents for NDA 020989

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Daiichi Sankyo Inc EVOXAC cevimeline hydrochloride CAPSULE;ORAL 020989-002 Jan 11, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Daiichi Sankyo Inc EVOXAC cevimeline hydrochloride CAPSULE;ORAL 020989-002 Jan 11, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Daiichi Sankyo Inc EVOXAC cevimeline hydrochloride CAPSULE;ORAL 020989-002 Jan 11, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Army
Argus Health
Deloitte
McKesson
Cantor Fitzgerald
Harvard Business School
Fish and Richardson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.